Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis

BACKGROUND: A rapid increase in bone turnover and bone loss has been observed in response to the discontinuation of denosumab. It led to an acute increase in the fracture risk, similar to that observed in the untreated patients. We aimed to investigate the effect of denosumab on osteoclast (OC) prec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Sung Hye, Kim, Jung Hee, Kim, Sang Wan, Jeong, Ae Jin, Lee, Song-Hee, Ye, Sang-Kyu, Shin, Chan Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Bone and Mineral Research 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208900/
https://www.ncbi.nlm.nih.gov/pubmed/35718926
http://dx.doi.org/10.11005/jbm.2022.29.2.93

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208900/
https://www.ncbi.nlm.nih.gov/pubmed/35718926
http://dx.doi.org/10.11005/jbm.2022.29.2.93

Ejemplares similares